Johnson & Johnson - 49 Year Stock Price History | JNJ
Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. The latest closing stock price for Johnson & Johnson as of October 18, 2019 is 127.70.
- The all-time high Johnson & Johnson stock closing price was 148.14 on January 22, 2018.
- The Johnson & Johnson 52-week high stock price is 148.99, which is 16.7% above the current share price.
- The Johnson & Johnson 52-week low stock price is 121.00, which is 5.2% below the current share price.
- The average Johnson & Johnson stock price for the last 52 weeks is 135.54.
| Johnson & Johnson Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2019 |
134.4910 |
127.7500 |
144.2400 |
125.7200 |
127.7000 |
-1.05% |
| 2018 |
133.0255 |
139.2300 |
148.1400 |
119.4000 |
129.0500 |
-7.64% |
| 2017 |
129.7608 |
115.8400 |
143.6200 |
111.7600 |
139.7200 |
21.27% |
| 2016 |
113.6073 |
100.4800 |
125.4000 |
95.7500 |
115.2100 |
12.16% |
| 2015 |
99.7594 |
104.5200 |
106.3900 |
90.7300 |
102.7200 |
-1.77% |
| 2014 |
100.8153 |
91.0300 |
109.0700 |
86.6200 |
104.5700 |
14.17% |
| 2013 |
85.7595 |
70.8400 |
95.6300 |
70.7400 |
91.5900 |
30.66% |
| 2012 |
66.9473 |
65.8800 |
72.5200 |
61.7800 |
70.1000 |
6.89% |
| 2011 |
63.5544 |
62.8200 |
67.9200 |
57.6600 |
65.5800 |
6.03% |
| 2010 |
62.1572 |
64.6800 |
66.0300 |
57.0200 |
61.8500 |
-3.97% |
| 2009 |
57.7864 |
60.6500 |
64.9600 |
46.6000 |
64.4100 |
7.66% |
| 2008 |
64.9140 |
65.9100 |
72.2200 |
55.3300 |
59.8300 |
-10.30% |
| 2007 |
63.9777 |
66.4000 |
68.4000 |
59.7700 |
66.7000 |
1.03% |
| 2006 |
62.2075 |
61.6300 |
69.1000 |
56.8000 |
66.0200 |
9.85% |
| 2005 |
64.6922 |
62.9000 |
69.4000 |
60.0400 |
60.1000 |
-5.23% |
| 2004 |
55.8880 |
51.6600 |
63.7600 |
49.5000 |
63.4200 |
22.76% |
| 2003 |
52.6021 |
55.3300 |
58.6700 |
48.7300 |
51.6600 |
-3.82% |
| 2002 |
57.6370 |
58.7000 |
65.4900 |
41.8500 |
53.7100 |
-9.12% |
| 2001 |
51.9361 |
51.0000 |
60.9700 |
41.6250 |
59.1000 |
12.46% |
| 2000 |
44.6343 |
46.0950 |
52.5500 |
34.2500 |
52.5500 |
12.71% |
| 1999 |
47.0157 |
41.3450 |
53.0500 |
38.5000 |
46.6250 |
11.17% |
| 1998 |
37.5132 |
32.5300 |
44.5000 |
32.0000 |
41.9400 |
27.32% |
| 1997 |
29.8362 |
24.8750 |
33.4700 |
24.8750 |
32.9400 |
32.42% |
| 1996 |
24.2629 |
21.0625 |
26.8750 |
21.0625 |
24.8750 |
16.37% |
| 1995 |
17.2058 |
13.6250 |
22.8750 |
13.4375 |
21.3750 |
56.16% |
| 1994 |
11.5482 |
11.3125 |
13.9375 |
9.1875 |
13.6875 |
21.99% |
| 1993 |
10.4992 |
12.3750 |
12.3750 |
8.9075 |
11.2200 |
-11.13% |
| 1992 |
12.3390 |
14.0313 |
14.5475 |
10.7825 |
12.6250 |
-11.79% |
| 1991 |
11.2061 |
8.7500 |
14.4375 |
8.2025 |
14.3125 |
59.58% |
| 1990 |
7.8557 |
7.4850 |
9.1725 |
6.5000 |
8.9688 |
20.83% |
| 1989 |
6.2566 |
5.2263 |
7.4225 |
5.2263 |
7.4225 |
39.52% |
| 1988 |
5.0606 |
4.8825 |
5.5075 |
4.3438 |
5.3200 |
13.68% |
| 1987 |
5.3868 |
4.2113 |
6.5388 |
4.0313 |
4.6800 |
14.11% |
| 1986 |
3.9821 |
3.2425 |
4.6175 |
2.9844 |
4.1013 |
24.71% |
| 1985 |
2.7837 |
2.2263 |
3.4219 |
2.1950 |
3.2888 |
45.68% |
| 1984 |
2.1431 |
2.5550 |
2.6488 |
1.7656 |
2.2575 |
-11.64% |
| 1983 |
2.8541 |
3.0938 |
3.1950 |
2.4531 |
2.5550 |
-17.62% |
| 1982 |
2.5529 |
2.2888 |
3.1875 |
2.0313 |
3.1013 |
33.68% |
| 1981 |
2.1350 |
2.0808 |
2.4063 |
1.7813 |
2.3200 |
11.64% |
| 1980 |
1.6533 |
1.5990 |
2.0833 |
1.3854 |
2.0781 |
25.87% |
| 1979 |
1.5022 |
1.5469 |
1.6667 |
1.3490 |
1.6510 |
7.45% |
| 1978 |
1.5989 |
1.5625 |
1.8490 |
1.3725 |
1.5365 |
-3.91% |
| 1977 |
1.4657 |
1.6275 |
1.6275 |
1.3048 |
1.5990 |
-1.60% |
| 1976 |
1.7987 |
1.8775 |
2.0025 |
1.5000 |
1.6250 |
-13.09% |
| 1975 |
1.8534 |
1.7292 |
2.0625 |
1.5365 |
1.8698 |
10.97% |
| 1974 |
2.0535 |
2.3281 |
2.4765 |
1.5650 |
1.6850 |
-28.27% |
| 1973 |
2.4765 |
2.6771 |
2.7188 |
2.1771 |
2.3490 |
-13.60% |
| 1972 |
2.4569 |
2.0365 |
2.7525 |
1.9765 |
2.7188 |
32.49% |
| 1971 |
1.7733 |
1.1927 |
2.0600 |
1.1927 |
2.0521 |
72.81% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$359.375B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
